Sort
15,273 grants matching “antimicrobial resistance”
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,982,734Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Exploring polyamine toxicity and resistance in epidemic bacterial skin pathogens
$2,976,652Anthony R. Richardson · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)
$2,964,560Timothy T Stedman · American Type Culture Collection · N01 · FY2012 · AI
Understanding resistance and tolerance to nitroimidazoles in Mycobacterium tuberculosis
$2,944,529Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$2,938,698Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2016 · AI
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Immunobiology for Marrow Allografts for Leukemia
$2,928,248Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
MIDAS Center for Communicable Disease Dynamics
$2,914,212Marc Lipsitch · Harvard School Of Public Health · U54 · FY2011 · GM
DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES
$2,901,309Anne Kathleen Radcliff · Cubrc, Inc. · N01 · FY2014 · AI
MIDAS Center for Communicable Disease Dynamics
$2,891,265Marc Lipsitch · Harvard School Of Public Health · U54 · FY2012 · GM
Advancing Public Health Research in Bangladesh
$2,879,788Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2021 · GH
Novel antibacterial agents for treatment of Tularemia
$2,864,024Affinium Pharmaceuticals, Inc. · U01 · FY2003 · AI
Bacterial cell wall remodeling, innate immunity, and pathogenesis
$2,841,668Francis Alonzo · University Of Illinois At Chicago · R01 · FY2025 · AI
Immunobiology for Marrow Allografts for Leukemia
$2,840,400Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Targeted Clinical Trials for Antimicrobial Resistance
$2,825,675Vance Fowler · Duke University · N01 · FY2011 · AI
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$2,819,529Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2017 · AI
Targeted Clinical Trials for Antimicrobial Resistance
$2,802,529Theoklis Zaoutis · Children'S Hosp Of Philadelphia · N01 · FY2012 · AI
MIDAS Center for Communicable Disease Dynamics
$2,791,232Marc Lipsitch · Harvard School Of Public Health · U54 · FY2013 · GM
Decoding the roles of critical genes of unknown function in M. tuberculosis
$2,782,563Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2015 · AI
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections
$2,779,955Mariette Barbier · West Virginia University · R01 · FY2025 · AI
Pathogen Data Network
$2,767,750Christophe Dessimoz · Swiss Institute Of Bioinformatics · U24 · FY2025 · AI
Algorithms and Software for the Assembly of Metagenomic Data
$2,764,928Mihai Pop · Univ Of Maryland, College Park · R01 · FY2025 · AI
PItt-Ohio State-Georgetown Clinical Trials Unit
$2,751,253John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2020 · AI
Clinical Trial for CA-MRSA Infections
$2,735,200Denise Tritt · Olive View-Ucla Education And Res Inst · N01 · FY2011 · AI